G3P-25749-74944 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-09-01
Dose 1 — Janssen/Johnson & Johnson
2021-09-02
Registered in v-safe
2021-09-02
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2021-09-03
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-09-04
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-09-05
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-09-06
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-09-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-09-08
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-09-15
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-09-22
Health check-in — day 21, single dose
Feeling: Good

Adult check-in
2021-09-29
Health check-in — day 28, single dose
Feeling: Good

Adult check-in
2021-10-06
Health check-in — day 35, single dose
Feeling: Good

Adult check-in
2021-10-13
Health check-in — day 42, single dose
Feeling: Good

Adult check-in
2021-12-01
Survey response — 3 months, dose 1
MedDRA: Pre-eclampsia — Feeling: Good · Be unable to work or attend school

Free text: Preeclampsia

MedDRA releases: 2024-11 · check-in free text available
2022-03-02
Health check-in — 6 months, dose 1
Feeling: Good

Adult check-in
2022-09-01
Survey response — 12 months, dose 1
MedDRA: Arthralgia, Asthenia, Chills, Myalgia, Sinus disorder, Sneezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Chills, weakness, muscle and joints pain, sinuses, sneezing.

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-09-01	Janssen/Johnson & Johnson	No

Free text

Release 10 — 3 months, dose 1

2021-12-01

Symptoms: Preeclampsia

Release 12 — 12 months, dose 1

2022-09-01

Symptoms: Chills, weakness, muscle and joints pain, sinuses, sneezing.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Arthralgia	·	·	✓
SD	Asthenia	·	·	✓
SD	Chills	·	·	✓
SD	Myalgia	·	·	✓
SD	Pre-eclampsia	·	·	✓
SD	Sinus disorder	·	·	✓
SD	Sneezing	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release